Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

US-friendly broker Finpari

 

Enter Stock Symbol:  

Sierra Oncology Inc (SRRA)

1.14 -0.03 (-2.56%)

6/26/2017  4:00pm

Open:

1.19

Pre. Close:

1.17

High:

1.22

Low:

1.14

Volume:

151,187

Market Cap:

59.59M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

-

-

Low:

-

-

Close:

-

-

Technical analysis  (as of: 2017-06-26 11:36:46 PM)

Overall:

      

Stoxline posted a SELL today, downgraded from higher rating. This stock seems to be ready for a new bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 1.46     One year: 1.57

Support:

Support1: 1.10    Support2: 0.92

Resistance:

Resistance1: 1.25    Resistance2: 1.34

Pivot:

1.18

Moving Averages:

MA(5): 1.16     MA(20): 1.18

MA(100): 1.36     MA(250): 1.57

MACD:

MACD(12,26): -0.03     Signal(12,26,9): -0.03

%K %D:

%K(14,3): 25.00     %D(3): 26.85

RSI:

RSI(14): 42.15

52-Week:

High: 2.25  Low: 1.10  Change(%): -42.1

Average Vol(K):

3-Month: 216  10-Days 255

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
SRRA has closed above bottom band by 25.7%. Bollinger Bands are 3.3% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Mon, 05 Jun 2017 11:44:12 GMT
Sierra Oncology shares jump 7.3% premarket on news of positive early-stage ...

Tue, 30 May 2017 11:03:47 GMT
Sierra Oncology Granted US and EU Patents for Chk1 inhibitor SRA737

Wed, 22 Feb 2017 16:18:45 GMT
With New Cash and Cancer Targets, Analyst Sees Almost 200% Upside in Sierra ...

Mon, 26 Jun 2017 15:37:10 GMT
Active Runner in Focus: Sierra Oncology Inc (SRRA)

Tue, 27 Jun 2017 02:37:30 GMT
Sierra Oncology Inc (SRRA): Inside the Numbers

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

52.27

Shares Float (M)

30.86

% Held by Insiders

% Held by Institutions

Shares Short (K)

879

Shares Short Prior Month (K)

918

Stock Financials

EPS

-1.450

EPS Est. Current Year

-0.900

EPS Est. Next Year

-0.820

EPS Est. Next Quarter

-0.220

Forward EPS

-0.820

Book Value (p.s.)

2.320

PEG Ratio

-0.02

Profit Margin

Operating Margin

Return on Assets (ttm)

-16.2

Return on Equity (ttm)

-37.6

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-0.665

Qtrly Earnings Growth

Operating Cash Flow (M)

-43.30

Levered Free Cash Flow (M)

-17.02

FoxReading.com

Valuation

P/E

-0.79

P/E Growth Ratio

-0.03

P/BV

0.49

P/S

P/CF

-1.38

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.